Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Revenue (Gross)Shares IssuedShares OutstandingShares OutstandingShort-Term Debt issuances
Ratios

Serina Therapeutics (SER) Cost of Revenue (2018 - 2023)

Serina Therapeutics (SER) has disclosed Cost of Revenue for 6 consecutive years, with $1000.0 as the latest value for Q4 2023.

  • Quarterly Cost of Revenue changed 0.0% to $1000.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $40000.0 through Dec 2023, up 207.69% year-over-year, with the annual reading at $40000.0 for FY2023, 207.69% up from the prior year.
  • Cost of Revenue hit $1000.0 in Q4 2023 for Serina Therapeutics, down from $33000.0 in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $79000.0 in Q4 2019 to a low of $1000.0 in Q1 2020.
  • Historically, Cost of Revenue has averaged $17100.0 across 5 years, with a median of $5000.0 in 2020.
  • Biggest five-year swings in Cost of Revenue: soared 1125.0% in 2019 and later tumbled 98.41% in 2020.
  • Year by year, Cost of Revenue stood at $79000.0 in 2019, then plummeted by 93.67% to $5000.0 in 2020, then plummeted by 80.0% to $1000.0 in 2021, then changed by 0.0% to $1000.0 in 2022, then changed by 0.0% to $1000.0 in 2023.
  • Business Quant data shows Cost of Revenue for SER at $1000.0 in Q4 2023, $33000.0 in Q3 2023, and $5000.0 in Q2 2023.